# The Value of 68Ga-FAPI PET/CT for Evaluating Peritoneal Treatment Response

> **NCT06957782** · NA · NOT_YET_RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 16 (estimated)

## Conditions studied

- Peritoneal Metastasis
- FAPI

## Interventions

- **DRUG:** ⁶⁸Ga-FAPI-46

## Key facts

- **NCT ID:** NCT06957782
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06957782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06957782, "The Value of 68Ga-FAPI PET/CT for Evaluating Peritoneal Treatment Response". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06957782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*